Literature DB >> 25496391

Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014.

Rebekah S McClain1, Deirdra R Terrell, Sara K Vesely, James N George.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25496391     DOI： 10.1111/trf.12917

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  6 in total

1.  Thrombotic microangiopathy: Caplacizumab accelerates resolution of acute acquired TTP.

Authors:  Bernhard Lämmle
Journal:  Nat Rev Nephrol       Date:  2016-04-04       Impact factor: 28.314

2.  Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015.

Authors:  Evaren E Page; Johanna A Kremer Hovinga; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Blood Adv       Date:  2017-04-06

Review 3.  Assessment and Monitoring of Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): Strategies to Improve Outcomes.

Authors:  Selin Kucukyurt; Ahmet Emre Eskazan
Journal:  J Blood Med       Date:  2020-09-28

4.  Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng; Sara K Vesely; Spero R Cataland; Paul Coppo; Brian Geldziler; Alfonso Iorio; Masanori Matsumoto; Reem A Mustafa; Menaka Pai; Gail Rock; Lene Russell; Rawan Tarawneh; Julie Valdes; Flora Peyvandi
Journal:  J Thromb Haemost       Date:  2020-09-11       Impact factor: 5.824

5.  Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.

Authors:  Elie Azoulay; Philippe R Bauer; Eric Mariotte; Lene Russell; Paul Knoebl; Ignacio Martin-Loeches; Frédéric Pène; Kathryn Puxty; Pedro Povoa; Andreas Barratt-Due; Jose Garnacho-Montero; Julia Wendon; Laveena Munshi; Dominique Benoit; Michael von Bergwelt-Baildon; Marco Maggiorini; Paul Coppo; Spero Cataland; Agnès Veyradier; Andry Van de Louw
Journal:  Intensive Care Med       Date:  2019-10-07       Impact factor: 17.440

Review 6.  Clinical Efficacy and Safety Profile of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.

Authors:  Muhammad Haisum Maqsood; Kinza Rubab; Muhammad Zaigham Maqsood
Journal:  Cureus       Date:  2019-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.